General Information of Drug (ID: DM2HLGC)

Drug Name
DZ9 Drug Info
Synonyms
CHEMBL1084955; 3-amino-N-(3-fluorophenyl)-6-thiophen-2-ylthieno[2,3-b]pyridine-2-carboxamide; 3hfj; NadD inhibitor 3_02; AC1MMP3S; SCHEMBL11887601; HMS1801K16; RSC004746; BDBM50318653; NCGC00100444-01; EU-0014464; US8785499, 3_02; 3-amino-N-(3-fluorophenyl)-6-(thiophen-2-yl)thieno[2,3-b]pyridine-2-carboxamide; DZ9
Cross-matching ID
PubChem CID
3289443
TTD Drug ID
DM2HLGC

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AC1LJNG0 DM9Q0EC N. A. N. A. Patented [1]
STK696827 DM19GAY N. A. N. A. Patented [1]
Nicotinamide-Adenine-Dinucleotide DM9LRKB N. A. N. A. Investigative [2]
Deamido-NAD DMDFRTI N. A. N. A. Investigative [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial Nicotinate-nucleotide adenylyltransferase (Bact nadD) TT1NFO3 NADD_ECOLI Inhibitor [1]

References

1 Targeting NAD biosynthesis in bacterial pathogens. US8785499.
2 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
3 Crystal structures of E. coli nicotinate mononucleotide adenylyltransferase and its complex with deamido-NAD. Structure. 2002 Jan;10(1):69-79.